3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Anemia, Refractory, with Excess of Blasts
3
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Anemia, Refractory
1
Interventions
Cytarabine
4
Azacitidine
4
venetoclax
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Injections
3
Biopsy
3
pegylated granulocyte colony-stimulating factor
2
Tacrolimus
2
Mitoxantrone
2
Gemtuzumab
2
Decitabine
2
Daunorubicin
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
Bone Marrow Transplantation
2
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
fedratinib
1
enasidenib
1
aldesleukin
1
Thiotepa
1
Spinal Puncture
1
Specimen Handling
1
Social Determinants of Health
1
Sirolimus
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mycophenolic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Monocytic, Acute
×
Cord Blood Stem Cell Transplantation
×
1 year
×
Clear all
No trials found.